71 related articles for article (PubMed ID: 22889408)
1. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment.
Kefeli U; Yildirim ME; Aydin D; Madenci OC; Yasar N; Sener N; Mert AG; Yuksel S; Ercelep OB; Korkmaz T; Yildiz R; Gumus M
Biomarkers; 2012 Nov; 17(7):663-7. PubMed ID: 22889408
[TBL] [Abstract][Full Text] [Related]
2. The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.
Yıldırım ME; Kefeli U; Aydın D; Sener N; Gümüş M
Tumour Biol; 2016 Sep; 37(9):11903-11907. PubMed ID: 27067437
[TBL] [Abstract][Full Text] [Related]
3. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
Seo HY; Park JM; Park KH; Kim SJ; Oh SC; Kim BS; Kim YH; Kim JS
Jpn J Clin Oncol; 2010 Dec; 40(12):1147-53. PubMed ID: 20647232
[TBL] [Abstract][Full Text] [Related]
5. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
8. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
[TBL] [Abstract][Full Text] [Related]
10. Is SCUBE 1 a new biomarker for gastric cancer?
Mentese A; Fidan E; Sumer AU; Karahan SC; Sonmez M; Altay DU; Kavgaci H; Alver A
Cancer Biomark; 2012; 11(5):191-5. PubMed ID: 23220851
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
[TBL] [Abstract][Full Text] [Related]
12. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
Guo E; Chen L; Xie Q; Chen J; Tang Z; Wu Y
Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
14. Serum midkine concentrations and gastric cancer.
Obata Y; Kikuchi S; Lin Y; Yagyu K; Muramatsu T; Kumai H;
Cancer Sci; 2005 Jan; 96(1):54-6. PubMed ID: 15649256
[TBL] [Abstract][Full Text] [Related]
15. Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers.
Aghcheli K; Parsian H; Qujeq D; Talebi M; Mosapour A; Khalilipour E; Islami F; Semnani S; Malekzadeh R
Eur J Intern Med; 2012 Jan; 23(1):58-64. PubMed ID: 22153533
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatocyte growth factor level associate with gastric cancer progression.
Wu CW; Chi CW; Su TL; Liu TY; Lui WY; P'eng FK
Anticancer Res; 1998; 18(5B):3657-9. PubMed ID: 9854473
[TBL] [Abstract][Full Text] [Related]
18. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients.
Alexiou D; Karayiannakis AJ; Syrigos KN; Zbar A; Sekara E; Michail P; Rosenberg T; Diamantis T
Am J Gastroenterol; 2003 Feb; 98(2):478-85. PubMed ID: 12591072
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
Potrc S; Gadiijev E; Hajdinjak T; Kavalar R
Hepatogastroenterology; 2007; 54(73):308-14. PubMed ID: 17419281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]